The START Center for Cancer Research (“START”) is the world’s largest early phase site network, fully dedicated to oncology clinical research. Throughout our history, START has provided hope to cancer patients in global community practices by offering access to cutting edge trials throughout the US and Europe. Today, with over 1,300 studies completed, and with research facilities in the United States and in Spain, Portugal, and Ireland, START’s mission is to accelerate the development of new anticancer drugs that will improve the quality of life and survival for patients with cancer and lead to its eventual cure. To date, over 43 therapies conducted at START locations have obtained FDA/EMA approval. Incredibly, while Academic Medical Centers (AMCs) conduct 80% of cancer trials, such trials reach only 20% of the patient population – leaving the majority of patients who are treated in community practices and hospitals without access to a clinical trial when their care journey calls for one. START serves the many – by bringing cancer trials to physicians and their patients in community hospitals and practices when hope is needed most.
START represents the world’s largest roster of Principal Investigators (PIs) across its eight clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world. As an example, in San Antonio, where START was founded, START treated the first patient ever with Keytruda – the most effective cancer drug in medical history.
Essential Responsibilities
Education & Experience
Physical & Travel Requirements:
Best-in-Class Benefits and Perks
We value our employees’ time and efforts. Our commitment to your success is enhanced by a competitive compensation, depending on experience, and an extensive benefits package including:
More about The START Center for Cancer Research
Deeply rooted in community oncology centers globally, The START Center for Cancer Research provides access to specialized preclinical and early-phase clinical trials of novel anti-cancer agents. START clinical trial sites have conducted more than a thousand early-phase clinical trials, including for 43 therapies that were approved by the FDA. START represents the world’s largest roster of Principal Investigators (PIs) across its eight clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world. Learn more at STARTresearch.com .
...countries around the world. We are committed to turning innovative science into medical solutions that bring value and hope to patients... ...business with ethics and integrity enables us to improve the health of people throughout the world. For more information on Astellas...
...teeth as managers-helping lead creative teams and presenting to clients. When it comes to craft, the Associate Creative Director, Art is not only fluent as an Art Director, they also have a solid amount of production experience under their belt. They have a strong opinion...
...place to work. We are looking to hire a Senior Director, Global Procurement to join the corporate procurement team based at our... ...maximizing value for McCormick, optimizing and protecting the supply chain, ensuring a responsible, sustainable, and continuous supply of...
.... As one of the first marketing hires, you will be responsible for our company's growth and ultimate success. About the Social Media Manager Position Our organization is in need of a talented Social Media Manager to manage our accounts. The Social Media Manager...
...As the Building Maintenance Technician Part Time, you will be responsible for overseeing the... ...minimize disruptions to operations. You will assist in the setup and breakdown of meeting... ...in the area. It's Harry Smead/David Gill design features tree-lined fairways, intricately...